selected scholarly activity
-
chapters
- PHYTOTHERAPEUTICS FOR CANCER THERAPY. 394-428. 2015
- Alternative Therapies as Primary Treatments for Cancer. 714-763. 2014
- Acupuncture and Moxibustion for Cancer-Related Symptoms. 83-120. 2012
- Safety and Side Effects of Acupuncture and Moxibustion as a Therapy for Cancer. 265-289. 2012
- Increasing Therapeutic Gain and Controlling Radiation-Induced Injuries with Asian Botanicals and Acupuncture. 109-139. 2010
- Supportive Cancer Care Using Chinese Medicine. 1-37. 2010
- The Scientific Basis of Chinese Medicine and Cancer Care: A Western Medicine Perspective. 1-54. 2007
- The Neurobiology of Consciousness and Spiritual Transformation in Healing. 285-306. 2005
-
conferences
- Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC).. Journal of Clinical Oncology. 2023
- THE EVOLUTION OF TECHNOLOGY IN THE MANAGEMENT OF EARLY-STAGE (T1) CANCER OF THE LARYNX, AN INSTITUTIONAL REVIEW OF RADIATION THERAPY OUTCOMES. Radiotherapy and Oncology. S74-S74. 2022
- Comparison of Recurrence With High Retropharyngeal Nodal-Sparing Intensity-Modulated Radiation Therapy in HPV-Related and HPV-Unrelated Oropharyngeal Cancer. International Journal of Radiation Oncology Biology Physics. e411-e411. 2021
- Does Modern Mediastinal Irradiation Cause Acute Subclinical Cardiac Toxicity? The Final Results of the MEDICATE Study (Mediastinal Irradiation and Cardio-Toxic Effects). International Journal of Radiation Oncology Biology Physics. S88-S89. 2018
- Phase 2 Study of “0-7-21” Hypofractionated Palliative Radiation Therapy for Advanced Head and Neck Squamous Cell Carcinoma. International Journal of Radiation Oncology Biology Physics. S128-S128. 2015
- Acupuncture-Like Transcutaneous Electrical Nerve Stimulation Versus Pilocarpine in Treating Radiation-Induced Xerostomia: Results of RTOG 0537 Phase 3 Study. International Journal of Radiation Oncology Biology Physics. 220-227. 2015
- Lifestyle interventions combined with acupuncture-like transcutaneous electrical nerve stimulation in managing vasomotor symptoms induced by breast cancer treatment: Results of a phase 2 randomized controlled trial. Cancer Research. 2015
- 0-7-21 Hypofractionated Palliative Radiation Therapy in Advanced Head-and-Neck Cancers: A Retrospective Study. International Journal of Radiation Oncology Biology Physics. 476-477. 2014
- A Preliminary Series of the Use of Stereotactic Radiosurgery (SBRT) in High-Risk Head-and-Neck Cancer. International Journal of Radiation Oncology Biology Physics. S429-S430. 2013
- RTOG 0537 Phase 2/3 Study Comparing Acupuncture-Like Transcutaneous Electrical Nerve Stimulation (ALTENS) Versus Pilocarpine (PC) in Treating Early Radiation-Induced Xerostomia (RIX): Phase 3 Preliminary Analysis. International Journal of Radiation Oncology Biology Physics. S116-S116. 2013
- Retrospective Study of Hypofractionated Palliative Radiation Therapy for Advanced Head-and-Neck Cancers 0-7-21. International Journal of Radiation Oncology Biology Physics. S521-S521. 2012
- A randomized phase III trial of magic mouthwash and sucralfate versus benzydamine hydrochloride for prophylaxis of radiation-induced oral mucositis in head and neck cancer.. Journal of Clinical Oncology. 5521-5521. 2011
- RTOG 0537 Phase II/III Study Comparing Acupuncture-like Transcutaneous Electrical Nerve Stimulation (ALTENS) versus Pilocarpine in Treating Early Radiation-Induced Xerostomia (RIX): Phase II Results. International Journal of Radiation Oncology Biology Physics. S79-S80. 2010
- LACK OF CARDIAC EFFECTS FOLLOWING THERAPEUTIC AND SUPRATHERAPEUTIC DOSAGES OF CLOBAZAM. Journal of Clinical Pharmacology. 1081-1081. 2010
- Determining Patterns of Therapy Choice in Patients Treated for Early Stage, Aggressive Histology Non-Hodgkin's Lymphoma. International Journal of Radiation Oncology Biology Physics. S484-S485. 2009
- PHASE II TRIAL OF CONVENTIONAL RADIOTHERAPY WITH STEREOTACTIC RADIOSURGERY TO HIGH-RISK TUMOR REGIONS AS DETERMINED BY MR SPECTROSCOPY IN PATIENTS WITH GLIOBLASTOMA MULTIFORME. Neuro-Oncology. 664-664. 2009
- 17 DETERMINING PATTERNS OF THERAPY CHOICE IN PATIENTS TREATED FOR EARLY STAGE, AGGRESSIVE HISTOLOGY NONHODGKIN'S LYMPHOMA. Radiotherapy and Oncology. S6-S6. 2009
- 2406. International Journal of Radiation Oncology Biology Physics. S436-S436. 2006
- 26. International Journal of Radiation Oncology Biology Physics. S15-S15. 2006
- 10 Acute phase response reactants as an objective measure of mucosal toxicity in head and neck cancer patients undergoing radical radiation therapy with or without concurrent chemo-therapy. Radiotherapy and Oncology. S3-S3. 2006
- 138 Inflammatory serum markers as an objective measure of radiation mucositis in head and neck cancer. Radiotherapy and Oncology. S41-S41. 2005
- A study examining epidermal growth factor receptor, p53, and Bcl-2 expression in patients with locally advanced squamous cell carcinoma of the head and neck treated with concomitant chemoradiotherapy. Lung Cancer. S82-S83. 2004
-
journal articles
- Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC).. Journal of Clinical Oncology. 41:6054-6054. 2023
- A phase 2 study of stereotactic body radiation therapy for squamous cell carcinoma of the head and neck (SHINE): a single arm clinical trial protocol. BMC Cancer. 23:379. 2023
- 37: Comparison of Recurrence with High Retropharyngeal Nodal-Sparing Radiation Technique in HPV-Related and HPV-Unrelated Oropharyngeal Cancer in the IMRT Era. Radiotherapy and Oncology. 163:S18-S19. 2021
- A post-hoc subgroup analysis assessing acute cardiac biomarker profiles in female cancer patients during adjuvant therapy. Clinica Chimica Acta. 495:355-357. 2019
- MEDiastinal Irradiation and CArdio-Toxic Effects (MEDICATE): Exploring the Relationship between Cardiac Irradiation and High Sensitivity Troponins. Clinical Oncology. 31:479-485. 2019
- Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire—RTOG Modification. Journal of Pain and Symptom Management. 53:139-145.e2. 2017
- Integrative oncology: are we doing enough to integrate psycho-education?. Future Oncology. 12:2779-2783. 2016
- Xerostomia health-related quality of life: NRG oncology RTOG 0537. Quality of Life Research. 25:2323-2333. 2016
- Phase 2 Study of Acupuncture-Like Transcutaneous Nerve Stimulation for Chemotherapy-Induced Peripheral Neuropathy. Integrative Cancer Therapies. 15:153-164. 2016
- 0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers. British Journal of Radiology. 88:20140646-20140646. 2015
- Patient-Centered care in Cancer Treatment Programs: The Future of Integrative Oncology Through Psychoeducation. Future Oncology. 10:2603-2614. 2014
-
The
M ozart effect: does it add to self‐soothing?. Focus on Alternative and Complementary Therapies. 19:167-168. 2014 - Randomized Trial of Hyperfractionation Versus Conventional Fractionation in T2 Squamous Cell Carcinoma of the Vocal Cord (RTOG 9512). International Journal of Radiation Oncology Biology Physics. 89:958-963. 2014
- Flax and Breast Cancer. Integrative Cancer Therapies. 13:181-192. 2014
- Black Cohosh and Breast Cancer. Integrative Cancer Therapies. 13:12-29. 2014
- Canadian Integrative Oncology Research Priorities: Results of a Consensus-Building Process. Current Oncology. 20:289-299. 2013
- Mixing chalk and cheese: the challenge for integrating complementary therapies into radiation oncology. Focus on Alternative and Complementary Therapies. 18:64-69. 2013
- Soy, Red Clover, and Isoflavones and Breast Cancer: A Systematic Review. PLoS ONE. 8:e81968-e81968. 2013
- Phase II Trial of Radiosurgery to Magnetic Resonance Spectroscopy–Defined High-Risk Tumor Volumes in Patients With Glioblastoma Multiforme. International Journal of Radiation Oncology Biology Physics. 84:668-674. 2012
- Phase 2 results from Radiation Therapy Oncology Group Study 0537. Cancer. 118:4244-4252. 2012
- Sweet Bee Venom Pharmacopuncture for Chemotherapy-Induced Peripheral Neuropathy. JAMS Journal of Acupuncture and Meridian Studies. 5:156-165. 2012
- Acute‐phase response reactants as objective biomarkers of radiation‐induced mucositis in head and neck cancer. Head and Neck. 34:985-993. 2012
- Effects of Sweet Bee Venom Pharmacopuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy. Integrative Cancer Therapies. 11:166-171. 2012
- Systems Modeling in Integrative Oncology. Integrative Cancer Therapies. 11:5-17. 2012
- 5.29 Potential of AFX-2, a Unique, Polysaccharide-Based Toll-like Receptor Agonist, in Patients With Chronic Lymphocytic Leukemia. Clinical Lymphoma, Myeloma and Leukemia. 11:S262-S263. 2011
- Alterations in Resting-State BOLD MRI Fractal Dimension After Swedish Massage. Critical Reviews in Physical and Rehabilitation Medicine. 23:241-252. 2011
- Selenium and Lung Cancer: A Systematic Review and Meta Analysis. PLoS ONE. 6:e26259-e26259. 2011
- Vitamin A and Retinoid Derivatives for Lung Cancer: A Systematic Review and Meta Analysis. PLoS ONE. 6:e21107-e21107. 2011
- Using oriental medicine symptom patterns to identify prostatic hyperplasia patients who may benefit from oriental therapies. Focus on Alternative and Complementary Therapies. 15:310-312. 2010
- To the Editors. Neuro-Ophthalmology. 34:81-81. 2010
- Can the Therapeutic Gain of Radiotherapy Be Increased by Concurrent Administration of Asian Botanicals?. Integrative Cancer Therapies. 9:5-13. 2010
- Phase II Randomized Trial of Acupuncture-Like Transcutaneous Electrical Nerve Stimulation to Prevent Radiation-Induced Xerostomia in Head and Neck Cancer Patients.. Society for Integrative Oncology. 8:35-42. 2010
- Phase II Trial Combining Conventional Radiotherapy with Stereotactic Radiosurgery to High-risk Tumor Regions as Determined by MR Spectroscopy for Patients with Glioblastoma Multiforme. International Journal of Radiation Oncology Biology Physics. 75:S124-S124. 2009
- Selenium and vitamin E supplements do not prevent prostate cancer: the importance of prospective RCTs for definitive practice guidelines. Focus on Alternative and Complementary Therapies. 14:183-184. 2009
- The role of integrative oncology in a tertiary prevention survivorship program. Preventive Medicine. 49:93-98. 2009
- Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals (2009).. Society for Integrative Oncology. 7:83-84. 2009
- Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.. Society for Integrative Oncology. 7:85-120. 2009
- Response: Re: Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?. Journal of the National Cancer Institute. 100:1559-1560. 2008
- Clinical audit of an integrative oncology programme: how should we measure outcome?. Focus on Alternative and Complementary Therapies. 13:168-172. 2008
- How Do We Evaluate Outcome in an Integrative Oncology Program?. Current Oncology. 15:78-82. 2008
- Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan–Kettering Experience. Current Oncology. 15:108-108. 2008
- Integrative Oncology: A Canadian and International Perspective. Current Oncology. 15:71-73. 2008
- Integrative Oncology: A Canadian and International Perspective. Current Oncology. 15:s71-s73. 2008
- Research and Regulatory Issues for Integrative Oncology. Current Oncology. 15:107-108. 2008
- The Integrative Oncology Supplement—A Paradigm for Both Patient Care and Communication. Current Oncology. 15:166-167. 2008
- Should Supplemental Antioxidant Administration Be Avoided During Chemotherapy and Radiation Therapy?. Journal of the National Cancer Institute. 100:773-783. 2008
- Acupuncture as an Evidence-Based Option for Symptom Control in Cancer Patients. Current Treatment Options in Oncology. 9:117-126. 2008
- Is there a role for acupuncture for the treatment of hot flushes in breast cancer patients?. Focus on Alternative and Complementary Therapies. 13:112-113. 2008
- Chinese Medicine and Biomodulation in Cancer Patients—Part One. Current Oncology. 15:42-48. 2008
- Chinese Medicine and Biomodulation in Cancer Patients—Part Two. Current Oncology. 15:78-78. 2008
- Research and regulatory issues for integrative oncology. Current Oncology. 15:S53-S63. 2008
- The integrative oncology supplement - A paradigm for both patient care and communication. Current Oncology. 15:1-2. 2008
- Polysaccharide extracts from Chinese medicinal herbs have a role in enhancing innate immunity. Focus on Alternative and Complementary Therapies. 12:43-43. 2007
- Promoting research guidelines for natural health products (NHPs) in oncology. Focus on Alternative and Complementary Therapies. 12:42-42. 2007
- Homeopathy for cancer?. Current Oncology. 14:128-130. 2007
- Homeopathy: Does a Teaspoon of Honey Help the Medicine Go Down?. Current Oncology. 14:126-127. 2007
- Future Directions for Research onSilybum marianumfor Cancer Patients. Integrative Cancer Therapies. 6:166-173. 2007
- Massage Therapy for Cancer Patients: A Reciprocal Relationship between Body and Mind. Current Oncology. 14:45-56. 2007
- New Multidisciplinary Prostate Bone Metastases Clinic: First of Its Kind in Canada. Current Oncology. 14:9-12. 2007
- Integrative Oncology Practice Guidelines. Society for Integrative Oncology. 05:65-65. 2007
- Research on Therapeutic Massage for Cancer Patients: Potential Biologic Mechanisms. Society for Integrative Oncology. 05:155-155. 2007
- Acupuncture Treatment for Chemotherapy-Induced Peripheral Neuropathy – a Case Series. Acupuncture in Medicine. 24:87-91. 2006
- Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 2. Current Oncology. 13:99-107. 2006
- Targeting Angiogenesis With Integrative Cancer Therapies. Integrative Cancer Therapies. 5:9-29. 2006
- Natural Health Products That Inhibit Angiogenesis: A Potential Source for Investigational New Agents to Treat Cancer—Part 1. Current Oncology. 13:14-26. 2006
- Integrative oncology in North America.. Society for Integrative Oncology. 4:27-39. 2006
- Chemotherapy plus high‐dose antioxidants for non‐small‐cell lung cancer: no significant influence on outcome. Focus on Alternative and Complementary Therapies. 10:294-296. 2005
- Second primary cancer prevention: the conundrum of antioxidants. Focus on Alternative and Complementary Therapies. 10:293-294. 2005
- Dissociation between radiotherapy patients’ experience of anxiety and their sense of well-being after hypnotherapy. Focus on Alternative and Complementary Therapies. 10:219-220. 2005
- High‐dose antioxidants to prevent cancer: hype or hoax?. Focus on Alternative and Complementary Therapies. 10:29-31. 2005
- High‐touch cancer care associated with improved symptom control. Focus on Alternative and Complementary Therapies. 10:47-48. 2005
- Integrative oncology for comprehensive cancer centres: Definitions, scope, and policy. Current Oncology. 12:103-117. 2005
- Should patients take or avoid antioxidant supplements during anticancer therapy? An evidence-based review. Current Oncology. 12:44-54. 2005
- Antioxidants during anticancer therapy. Focus on Alternative and Complementary Therapies. 9:96-106. 2004
- Thyroid function screening following radiation therapy for cancers of the head and neck: A survey of Canadian practice patterns. Current Oncology. 11:68-71. 2004
- A Phase I–II study in the use of acupuncture-like transcutaneous nerve stimulation in the treatment of radiation-induced xerostomia in head-and-neck cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology Biology Physics. 57:472-480. 2003
- Motexafin gadolinium (MGd) overcomes adverse survival effect of anemia in brain metastases (BM) patients treated with whole brain radiation therapy (WBRT): analysis of a phase III randomized trial. International Journal of Radiation Oncology Biology Physics. 57:S133-S133. 2003
- O-66 Impact of whole brain radiation therapy (WBRT) and motexafin gadolinium (MGd) on neurologic and neurocognitive progression in non-small cell lung cancer (NSCLC) patients with brain metastases: Results of a randomized phase III trial. Lung Cancer. 41:S22-S22. 2003
- P-465 Differences in baseline characteristics between non-small cell lung cancer (NSCLC) and breast cancer (BrCa) patients with brain metastases. Lung Cancer. 41:S208-S209. 2003
- Chinese medicine and supportive cancer care. Evidence-Based Integrative Medicine. 1:11-25. 2003
- Integrative Tumor Board: Recently Diagnosed Lung Cancer. Integrative Cancer Therapies. 1:246-249. 2002
- Radiation Oncology and Mind-Body Medicine Analysis. Integrative Cancer Therapies. 1:259-261. 2002
- Integrative Tumor Board: Advanced Breast Cancer. Integrative Cancer Therapies. 1:179-182. 2002
- Radiation Oncology and Complementary Care Analysis. Integrative Cancer Therapies. 1:184-185. 2002
- The use of acupuncture-like transcutaneous nerve stimulation (CODETRON) in the treatment of radiation-induced xerostomia in head and neck cancer patients treated with radical radiotherapy. International Journal of Radiation Oncology Biology Physics. 51:411-411. 2001
- Integration of Chinese medicine into supportive cancer care:A modern role for an ancient tradition. Cancer Treatment Reviews. 27:235-246. 2001
- The Treatment of Persistent Yawning with Acupuncture. Acupuncture in Medicine. 18:124-126. 2000
- The effects of stress on oncology staff.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 163:807. 2000
- Alternative views on alternative therapies.. CANADIAN MEDICAL ASSOCIATION JOURNAL. 160:1697-1699. 1999
- No guidance is provided for situations for which evidence is lacking. The BMJ. 311:258-258. 1995
- Nitric oxide and anti-cancer therapy. Cancer Treatment Reviews. 21:159-181. 1995
- A clinical audit of glottic cancer in Nova Scotia: A paradigm for effectiveness research. Clinical Oncology. 6:14-23. 1994
- Tumour blood flow: measurement and manipulation for therapeutic gain. Cancer Treatment Reviews. 19:299-349. 1993
-
Progress in cancer treatment symptom control. Alleviation of emesis by the 5-HT
3 receptor antagonists. Nova Scotia Medical Journal. 72:9-10. 1993 - Treating elderly patients with breast cancer.. The BMJ. 304:1376-1377. 1992
- Metastatic parathyroid carcinoma: a radiological, biochemical and symptomatic response to metastectomy.. Journal of the Royal Society of Medicine. 85:182. 1992
- Metastasis to the penis from malignant melanoma: Case report and review of the literature. Clinical Oncology. 4:130-131. 1992
- The current role of anti-emetic drugs in oncology: a recent revolution in patient symptom control. Cancer Treatment Reviews. 18:95-135. 1991
- Ondansetron; further progress in the prevention of nausea and vomiting induced by anti-cancer chemotherapy. Clinical Oncology. 3:183-183. 1991
- Olfactory sensations produced by high-energy photon irradiation of the olfactory receptor mucosa in humans. International Journal of Radiation Oncology Biology Physics. 20:771-776. 1991
- Malignant lymphomatous polyposis: Diagnosis and response to chemotherapy. Clinical Oncology. 2:230-234. 1990
- What size chest tube for pleural effusions?. British journal of hospital medicine (London, England : 2005). 43:184. 1990
- OESTROGEN MODULATORS AND CLEAR CELL CARCINOMA OF VAGINA. The Lancet. 329:913-913. 1987
- THERAPY OF HYPONATREMIA. New England Journal of Medicine. 315:1353-1353. 1986
- Therapy of Hyponatremia. New England Journal of Medicine. 315:1351-1355. 1986
- Proposed Consensus-Based Canadian Integrative Oncology Research Priorities. International Journal of Whole Person Care. 1.